慢性阻塞性肺病医保与非医保患者抗菌药物利用分析.pdfVIP

·医保用药· 慢性阻塞性肺病“医保”与非“医保”患者抗菌药物利用分析 许进福。，熊世娟，黄成赛(贵州省人民医院药剂科，贵阳市550002) 中图分类号 R978．1；R969．3文献标识码 C 文章编号 1001—0408(2007)17—1286—03 摘要 啶、阿莫西林／克拉维酸钾、左氧氟沙星、阿奇霉素；非“医保”患者列前5位的分别为阿莫西林／克拉维酸钾、左氧氟沙星、头孢他啶、 患者占10．9％。结论：我院COPD“医保”与非“医保”患者抗茵药物应用基本合理，但应对存在的问题制定相应措施。 关键词慢性阻塞性肺病；医疗保险；抗茵药物；用药频度；合理用药 UseofAntibacterialsinMedicareandNon-—MedicarePatientswithChronicObstructive Dis- Pulmonary ease(COPD) XU Provincial Jinfu，XIONGuan，HUANG Pharmacy，GuizhouPeople’SHospital， Shij Chengsai(Dept．of 550002，China) Guiyang theuseofantibacterialsinmedicareandnon—medicarewithchronicob— ABSTRACToE|JECTIVE：To patients investigate was on171CoPD in structive disease(COPD)．METHoDS：A patients pulmonary retrospectiveanalysisperformed werenon—medicare our from to whom，107weremedicare and64 hospitalJan．1，2003Jun．30，2006(of patients useand utilization of tothe rate，DDDs，combineddrug index(DUI)etc respect application thefirst5 intermsofDDDswere sodium／sulbactam the hadused cefoperazone sodium， patients antibacteirals，toppingplaces themedicare and42．2％ofthe ceftazidime．amoxicillin／clavulanateand patients potassium，levofloxacinazithromycin．49．5％of non—medicare non—medicareusedtwokindsofantibacterials：15．0％ofthemedicare and10．9％ofthe pati